The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol

NCT00886860 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2010-07-14

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy for cervical ripening in labor induction between titrated and conventional oral misoprostol

Conditions

  • Cervical Ripening
  • Labor Induction

Interventions

DRUG

misoprostol

misoprostol 50 micrograms oral every 4 hours until cervical dilatation 3 cm

DRUG

misoprostol

misoprostol 20 micrograms oral every hours until cervical dilatation 3 cm

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Kusol Russameecharoen, MD · Siriraj Hospital, Mahidol University Bangkok, Bangkok, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-12-31
Completion
2010-03-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00886860 on ClinicalTrials.gov